Erasca Foundation plans $152K sale of 8,333 shares

Erasca Foundation filed a notice of proposed sale of Erasca, Inc. common stock under Form 144.

Rhea-AI Filing Summary

Erasca Foundation filed a notice of proposed sale of Erasca, Inc. common stock under Form 144. The filing lists a planned sale of 8,333 common shares of Erasca, Inc. through Merrill Lynch on NASDAQ with an aggregate value of $152,418.71.

The notice also references a prior donation of 10,193,557 common shares of Erasca, Inc. dated July 20, 2021, and reports sales during the past three months by Erasca Foundation of 8,333 shares for $157,637.52 on July 21, 2026 and 8,333 shares for $117,476.95 on June 15, 2026.

Key Figures

Proposed shares to be sold: 8,333 shares Proposed aggregate value: $152,418.71 Historical donation shares: 10,193,557 shares +4 more

7 metrics

Proposed shares to be sold 8,333 shares Common stock sale notice through Merrill Lynch on NASDAQ

Proposed aggregate value $152,418.71 Aggregate market value of 8,333 common shares proposed for sale

Historical donation shares 10,193,557 shares Donation of Erasca, Inc. common stock dated July 20, 2021

Shares sold July 21, 2026 8,333 shares Erasca Foundation sale of common stock during past 3 months

Proceeds July 21, 2026 sale $157,637.52 Amount received for 8,333 shares sold by Erasca Foundation

Shares sold June 15, 2026 8,333 shares Erasca Foundation sale of common stock during past 3 months

Proceeds June 15, 2026 sale $117,476.95 Amount received for 8,333 shares sold by Erasca Foundation

Key Terms

Form 144, aggregate value, donation

3 terms

Form 144 regulatory

"Erasca Foundation filed a notice of proposed sale of Erasca, Inc. common stock under Form 144"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

aggregate value financial

"with an aggregate value of $152,418.71"

donation financial

"a prior donation of 10,193,557 common shares of Erasca, Inc. dated July 20, 2021"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does ERAS’s latest Form 144 filing disclose?

The filing discloses a planned sale of 8,333 shares of Erasca, Inc. common stock with an aggregate value of $152,418.71, along with historical donation and prior sale activity by Erasca Foundation.

How many ERAS shares are proposed to be sold in this Form 144?

The notice lists a proposed sale of 8,333 common shares of Erasca, Inc. stock. These shares are to be sold through Merrill Lynch on NASDAQ with an aggregate listed value of $152,418.71 on August 17, 2026.

Who is selling ERAS shares according to this Form 144?

The filing identifies Erasca Foundation in connection with Erasca, Inc. common stock. It lists a proposed sale of 8,333 shares and prior sales and donations of Erasca common shares associated with the foundation.

What ERAS share sales occurred in the past three months?

Erasca Foundation reported two sales: 8,333 shares for $157,637.52 on July 21, 2026 and 8,333 shares for $117,476.95 on June 15, 2026. These transactions involve Erasca, Inc. common stock.

What large historical transaction involving ERAS shares is referenced?

The filing references a donation of 10,193,557 shares of Erasca, Inc. common stock dated July 20, 2021. This transaction is labeled as a donation of common shares rather than a market sale.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/17/2026 - 02:14 PM Accepted by SEC EDGAR 08/17/2026 - 02:13 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001973524
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Erasca, Inc.
SEC File Number	001-40602
Address of Issuer	3115 MERRYFIELD ROW STE 300 San Diego CALIFORNIA 92121
Phone	8584656511
Name of Person for Whose Account the Securities are To Be Sold	Erasca Foundation
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Foundation

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Merrill Lynch 6002 El Tordo PO Box 7297 Rancho Santa Fe CA 92067	8333	152418.71	349762035	08/17/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	07/20/2021	Donation	Erasca, Inc.			10193557	07/20/2021	Donation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Erasca Foundation 3115 MERRYFIELD ROW STE 300 San Diego CA 92121	Common	07/21/2026	8333	157637.52
Erasca Foundation 3115 MERRYFIELD ROW STE 300 San Diego CA 92121	Common	06/15/2026	8333	117476.95

144: Remarks and Signature

Remarks
Date of Notice	08/17/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	05/21/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Brian Baker
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)